Recuro Health At-Home COVID-19 Rapid Testing Solution Featured at U.S. Census Bureau & Department of Health & Human Services COVID-19 TOPx Solutions Showcase

DALLAS — (BUSINESS WIRE) — Recuro Health At-Home Testing (otherwise known as UDoTest), an at-home diagnostic and health screening software platform designed to personalize the at-home testing experience, announces that its COVID-19 rapid test solution will be featured at the HHS TOPx Solution Showcase, Thursday, May 25, 2021, 12-3 p.m. ET. The virtual event is co-hosted by the U.S. Census Bureau and in partnership with the U.S. Department of Health and Human ServicesAttendees will learn about the digital products created through the COVID-19 TOPx Technology Development Sprint designed to empower employer operational decision making and was modeled on The Opportunity Project (TOP), an innovation program led by Census Open Innovation Labs at the U.S. Census Bureau with input from leading government and industry experts.

Allison Martin, a founder and executive director, Recuro Health, explains, “We are honored to be among the 12 technology companies that were selected by the HHS COVID-19 At-Anywhere Diagnostics Design-a-thon and recognized for developing digital solutions to ensure that COVID-19 diagnostic testing data is efficiently, securely and accurately transmitted to key stakeholders, including federal, state, local and tribal governments, patients, providers, employers, schools, consumers and others. Through technology development sprints, TOPx engages government, technology experts and communities to co-create digital products for the public using federal-open data.”

Speaker highlights:

  • Ron Jarmin, acting director, U.S. Census Bureau
  • Micky Tripathi, national coordinator for health IT, U.S. Department of Health and Human
  • Services and U.S. Census Bureau Leadership
  • DJ Patil, former U.S. chief data scientist
  • Kristen Honey, senior advisor to assistant secretary for health, U.S Department of Health and Human Services
  • Sara Brenner, chief medical officer, in vitro diagnostics, U.S. Food and Drug Administration

Martin adds, “After a long year of lockdowns, businesses have suffered deep financial losses and the major push is on to get employees back to work. However, a return-to-work requires strong assurances of health and safety which has led to a massive need for affordable, accurate at-home or on-site, rapid testing that makes employees feel safe. Recuro is proud to be a recognized leader in innovative, global and award-winning testing.”

About Recuro Health

Serving employers, providers and payers, Recuro Health delivers value throughout the healthcare ecosystem with digital solutions that respond to ongoing changes in the health care system. As patient care moves from traditional office in-person settings to wherever the patient and data are located, these solutions support the migration from convenient care to meaningful patient engagement across broader care pathways. Holistic, integrated and interoperable solutions create a personalized digital medical home that results in better outcomes and lower costs. www.recurohealth.com

Contacts:

Media:
CPR for Recuro Health
Holly McKenna
Hmckenna@cpronline.com
1.518.461.8207

default-image3

Recuro Health Supports SIIA Annual Meeting: Provides Voluntary COVID-19 Antigen Rapid Testing for Attendees, CEO Michael Gorton Panel Presenter

DALLAS—(BUSINESS WIRE)—Recuro Health(Recuro), an integrated digital health solutions company that transitions the U.S. healthcare system from a reactive, disease-focused model to a population health, outcomes...